Irozorb Plus Oral Suspension is a carefully formulated hematinic preparation containing Iron (30mg), Cyanocobalamin (500mcg), and Folic Acid (500mcg) designed to effectively treat and prevent various types of anemia. Iron is a vital component of hemoglobin, essential for oxygen transport in the blood, while Cyanocobalamin (Vitamin B12) and Folic Acid play crucial roles in DNA synthesis and red blood cell formation. This combination addresses iron deficiency anemia, megaloblastic anemia due to Vitamin B12 and folate deficiency, and mixed anemia conditions. The oral suspension form ensures enhanced bioavailability and ease of administration, particularly beneficial for pediatric and geriatric patients or those with swallowing difficulties. Irozorb Plus supports the restoration of normal hemoglobin levels and replenishes depleted iron stores, improving symptoms such as fatigue, pallor, and weakness associated with anemia. It is indicated for use in nutritional supplementation during pregnancy, lactation, and periods of increased physiological demand. The product should be used under medical supervision, with dosage adjusted according to individual patient requirements and severity of deficiency. Regular monitoring of hematological parameters is recommended to assess therapeutic response and avoid potential iron overload or vitamin toxicity. Irozorb Plus Oral Suspension offers a comprehensive approach to anemia management through synergistic micronutrient supplementation.